Just after the first anniversary of listingJunyao Health (605388.SH)Received the decision of Hubei Securities Regulatory Bureau to order corrective measures.
On August 17, Junyao Health announced that on August 16, 2021, the company received a "Hubei Securities Regulatory Bureau's decision to order corrective measures against Hubei Junyao University Health Beverage Co., Ltd." issued by the Hubei Regulatory Bureau of the China Securities Regulatory Commission. Hubei Securities Regulatory Bureau found many differences in the data in Junyao's 2020 annual report and asked it to revise the relevant information in the 2020 annual report by August 30, 2021, and submit a written rectification report by August 30, 2021.
To this end, on the afternoon of August 18, Junyao Health issued the 2020 Annual report of Hubei Junyaoda Health Beverage Co., Ltd. (updated version) and the Supplementary Correction announcement on the 2020 Annual report, explaining the reasons for the differences in data and the changes in statistical caliber.
Junyao Health said it would make rectification in accordance with the requirements of Hubei Securities Supervision Bureau. The balance sheet of the company covered in the 2020 annual report,Profit statementThe major financial data, such as the statement of cash flows, are true and correct, which is consistent with the annual audit report issued by Dahua accountant's firm, and this order correction measures will not affect the objective and true reflection of the company's 2020 operating results. It will not affect the company's 2020 performance.
The reporter noticed that there are data differences and statistical caliber changes in Junyao health this time, mainly for some of the products "lactic acid bacteria drinks." the problems involved are mainly the differences between the statistical units of product production and sales, the difference between the sales volume and the sales volume disclosed in the text below, and so on.
According to the corrected annual report of Junyao Health in 2020, the operating income of lactobacillus drinks reached 770 million yuan, down 35.16% from the same period last year, production fell 33.82% from the same period last year, sales fell 28.37% from the same period last year, and the gross profit margin was 4.97% lower than last year.
Minsheng Securities has reported that Junyao Health before the large single product of lactobacillus beverage "taste power" faced the problem of product aging. Dairy analyst Song Liang told reporters: "the threshold in the field of probiotics is low, there are no technical barriers, with the entry of leading enterprises will inevitably intensify competition, for Junyao is bound to be greatly affected." Secondly, at present, there is no professional beverage standard for probiotics in our country, and the standardization of the market is not mature enough. Junyao does not have any advantages in the lactic acid bacteria market at present. "
In order to break the restriction of probiotic products, on December 21, 2020, Junyao Health injected 10 million yuan to set up Shanghai Junyao Natural Mineral Water Co., Ltd., cross-border distribution of natural mineral water.
However, Song Liang is not optimistic about Junyao's cross-border move. "Internet celebrity brands are rising, and foreign brands are eyeing covetously, leaving not many healthy markets for Junyao. For Junyao Health, the product line is a form, if the product itself does not have technical arbitrariness and resource barriers, homogeneous products will quickly pour into the market. "